| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |